HIGHLIGHTS
- What: The study provided the first genomic evidence of C. difficile ST35 among different floors and buildings within the hospital. The antibiotic resistance pattern in this study showed that the rates of resistance to ciprofloxacin, levofloxacin, and tetracycline were significantly lower than data from the previous study (Jin et_al, 2017). All CDI patients in the study had a history of piperacillin-tazobactam usage, underscoring the necessity for stringent control and monitoring of this antibiotic to mitigate CDI risk.
- Who: Liqing Hu from the Ladoke Akintola University of Technology, Nigeria have published the paper: Molecular characteristics . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.